General MedicationsOPHTHALMICGeneric
METRETON
PREDNISOLONE SODIUM PHOSPHATE
Standard Dose
EQ 0.5% PHOSPHATE
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary
Approval overview METRETON is listed in Drugs@FDA under application 083834 (ANDA).
Marketing status: Discontinued Active ingredient PREDNISOLONE SODIUM PHOSPHATE Form and strength SOLUTION/DROPS;OPHTHALMIC - EQ 0.5% PHOSPHATE Sponsor SCHERING Submission history See approval history documents.
Structured Monograph
Clinical summary
Approval overview METRETON is listed in Drugs@FDA under application 083834 (ANDA). Marketing status: Discontinued Active ingredient PREDNISOLONE SODIUM PHOSPHATE Form and strength SOLUTION/DROPS;OPHTHALMIC - EQ 0.5% PHOSPHATE Sponsor SCHERING Submission history See approval history documents.
Monitoring
- • Marketing status: Discontinued
Interaction Notes
- No interaction notes stored yet.